Supplement analysis backed by scientific evidence · PT

← All supplements
Moderate evidenceJoints & skin

Palmitoylethanolamide (PEA)

PEA is a naturally occurring fatty acid amide with a real, replicated analgesic signal in meta-analyses of chronic and neuropathic pain — larger than most supplements manage. The caveats are that much of the trial base comes from a single manufacturer's ultramicronized product and that blinding quality is uneven.

What the science says

  • Meaningful pain reduction in chronic pain trials Moderate evidence

    A meta-analysis restricted to double-blind randomized controlled trials found PEA significantly reduced pain intensity versus control, with a standardized mean difference around -1.1 to -1.3 on pooled analysis and effects emerging within 2-8 weeks. An earlier meta-analysis of 10 trials (n≈786) reported a mean reduction of roughly 1.7 points more than control on a 0-10 numeric rating scale, with a clear dose-response and a number-needed-to-treat around 1.5-2 in the pooled sciatic-pain data. Heterogeneity was high and several trials were open-label.

  • Neuropathic and nerve-compression pain is the best-supported use Moderate evidence

    The largest single dataset is a study of over 600 patients with sciatic pain from lumbar disc compression, where 600 mg/day of micronized PEA outperformed both 300 mg/day and placebo on VAS pain over 3 weeks. Diabetic peripheral neuropathy, carpal tunnel syndrome, and chemotherapy-induced neuropathy trials point the same direction, though individually small. Meta-analytic work in diabetic neuropathic pain supports a benefit with a reassuring tolerability profile.

  • Mechanism is plausible and non-opioid Moderate evidence

    PEA is an endogenous N-acylethanolamine that acts mainly through PPAR-α activation and by downregulating mast cell and glial activation, rather than binding cannabinoid receptors directly (its 'entourage' effect on anandamide is indirect). It is not psychoactive, has no known abuse potential, and does not act on opioid receptors — which is what makes it interesting as an adjunct rather than a replacement.

  • Formulation matters more than for most supplements Limited evidence

    PEA is poorly water-soluble and its absorption depends heavily on particle size; nearly all positive trials used micronized or ultramicronized preparations, largely from one Italian manufacturer. Standard non-micronized bulk powder has not been shown equivalent, and independent replication outside the originating research groups remains limited — a legitimate reason to hold the evidence at moderate rather than strong.

Dosage & safety

Studied doseThe standard studied regimen is 600 mg/day of ultramicronized or micronized PEA, often given as 300 mg twice daily; some trials load at 1,200 mg/day for the first 2-4 weeks then taper to 600 mg/day, and 300 mg/day has been less effective than 600 mg. Trials ran 3 weeks to 6 months. Effects build over weeks rather than acting acutely. Take with food, since absorption of this lipid improves with dietary fat.
SafetyOne of the better-tolerated compounds in this category: pooled trial data show adverse event rates comparable to placebo, with mild GI upset the most common complaint and no serious drug-related events reported across several thousand participants. No clinically significant drug interactions have been established, though it has not been formally studied with anticoagulants or with pain medications, and it is generally used alongside standard analgesics rather than instead of them. Regulatory status varies: in parts of the EU it is sold as a food for special medical purposes, in the US as a dietary supplement, and in Australia it has faced restrictions — check local status. Safety in pregnancy, breastfeeding, and children is not established. Not a prohibited substance in sport. Because most trials are short and industry-connected, and long-term (>6 month) safety data are sparse, periodic reassessment of whether it is still helping is sensible. Persistent or worsening neuropathic pain needs a medical diagnosis, not just a supplement.

Scientific references

Where to buy

California Gold Nutrition, PEA (Palmitoylethanolamide), 30 Veggie Capsules (300 mg per Capsule)

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Joints & skin